IMI is celebrating its 10th anniversary with a high-level event in Brussels on 27 June. Join us to meet IMI projects and explore their successes and the impact they are having on drug development.
IMI’s OncoTrack project developed colon cancer models which allow researchers to more accurately predict the effect of drugs on different types of colon cancer tumours. This and other project outputs are already helping some doctors in choosing the right drug for the right patient, and could lead to more effective treatments in the future.
Public-private drug research programme has - as yet - only provided limited examples of how it is delivering on its goals, an independent evaluation concludes
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.